GlassScriptPhysician profile
Nikki B Zite
NPI 1518065416
$9,716.29
in general payments reported to CMS, 2019-2025
14 companies · $46.51 in 2025
The $46.51 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $4,822 · 2022: $407 · 2023: $3,198 · 2024: $90.75 · 2025: $46.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,886 · Food and Beverage: $449.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,886.00 |
| Food and Beverage | $448.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $4,800.00 | 2020 | |
| Organon LLC | $3,231.70 | 2022-2025 | Nexplanon, Jada System |
| Mylan Specialty L.P. | $1,020.00 | 2019 | |
| Axonics, INC. | $324.85 | 2022-2023 | Axonics, Bulkamid |
| Merck Sharp & Dohme LLC | $115.28 | 2019-2020 | |
| Baxter Healthcare | $65.83 | 2024 | Perclot |
| Sumitomo Pharma America, INC. | $54.82 | 2023 | Gemtesa, Myfembree |
| Conmed Corporation | $24.92 | 2024 | |
| Abbvie INC. | $21.26 | 2023 | Liletta |
| Biohaven Pharmaceutical Holding Company LTD. | $18.16 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.02 | 2019 | |
| Therapeuticsmd, INC. | $11.41 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.04 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikki Zite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.